Follow Gossamer Bio, Inc.. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
9 Stories in coverage 1 Program 21 recruiting Registered trials 10-Q Nov 16 Latest SEC filing Nov 10 Latest story
Timeline 9 Pipeline 1 Trials 2
All9 Regulatory2 Trials and readouts1 Filings and people6
Pipeline by stage
Phase 3 1
Phase 3 primary completions, next 6 months
All trials by completion date Details
Headquarters San Diego, CA Incorporated Delaware Industry Pharmaceutical Preparations Also known as GOSS How the company describes itself Gossamer Bio develops seralutinib, a small molecule for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. source